These diseases affect a person's health critically by lowering immunity and resulting in chronic pain. The incidences of the aforementioned diseases are most commonly seen in adults and geriatric population.
1. Pain Management Devices Market
Pain Management Devices Market
Forecast to 2027 - COVID-19 Impact and
Global Analysis by Product Type
(Neuromodulation Devices, Ablation
Devices, Analgesic Infusion Pumps);
Application (Neuropathic Pain, Cancer
Pain, Facial Pain and Migraine,
Musculoskeletal Pain, Others); and
Geography
2. Current and future Market Scenario
The pain management devices market is expected to reach US$ 8,388.67 million in 2027 from US$ 4,527.31 million in
2019. The market is estimated to grow with a CAGR of 8.1% from 2020 to 2027.
Pain management devices are used for managing or controlling the pain caused due to medical conditions like arthritis,
injury, cancer, and others. Devices for pain management are used according to the severity of the pain, these devices are
widely used in hospitals during the pain management therapy.
The global pain management devices market is driven by factors such as increasing chronic pain incidences, rising
product launches, and growing geriatric population. However, lack of awareness regarding pain management is likely to
hinder the growth of the pain management devices market during the forecast period.
The key factors that are driving growth of the pain management devices market are increasing chronic pain incidences,
rising product launches, and growing geriatric population. Moreover, technological advancements in pain management
devices are likely to have positive impact on the market. However, the lack of awareness regarding pain management
and high cost of pain management devices are likely to restrict the market growth.
Pain Management Devices Market
3. Key Findings
The increasing incidences of chronic diseases such as cancer, cardiovascular diseases, neurovascular diseases, and
musculoskeletal diseases are likely to drive the growth of the pain management devices market. These diseases affect
a person's health critically by lowering immunity and resulting in chronic pain.
The incidences of the aforementioned diseases are most commonly seen in adults and geriatric population. According
to the Centers for Disease Control and Prevention data of October 2019, in the US, 6 in 10 adults live with at least one
chronic disease. Additionally, in the US, 4 in 10 adults live with two types of chronic disease. Moreover, it has been
observed that the aforementioned diseases are noticeably increasing among children.
The incidences of chronic pain are commonly seen among athletes, sportspersons, and people living with past injuries.
The chronic pain incidences increase the dependency of a person on others for various daily activities. Therefore, pain
management is essential to carry out normal daily routine.
The pain management devices provide relief for longer durations and also improve their health. A wearable pain
management device is easy to use and operate; thus, it reduces the person's dependency on others. Therefore, owing
to the advantages of pain management devices, the demand for the same is rising among patients with chronic
diseases.
4. Market Segments
Pain Management Devices Market
By Product Type
(Neuromodulation Devices,
Ablation Devices, Analgesic
Infusion Pumps)
Application (Neuropathic Pain,
Cancer Pain, Facial Pain and
Migraine, Musculoskeletal
Pain, Others)
By Geography
North America
Europe
Asia Pacific (APAC)
Middle East and Africa (MEA)
South America
5. Dominating Segments
Based on the type, the global pain management devices market is segmented into neuromodulation devices,
ablation devices, and analgesic infusion pumps. The neuromodulation devices segment held the largest share
of the market in 2019;
However, the ablation devices segment is estimated to register the highest CAGR in the market during the
forecast period. Growing demand for minimally invasive surgeries and product developments by the market
players are likely to enhance the market growth of the segment during the forecast period.
In February 2019, Medtronic received FDA approval and launched its Accurian radiofrequency ablation
system for treatment of chronic pain in the US. Based on application, the pain management devices market is
segmented into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and others.
Pain Management Devices Market
6. Product Insights
Application Insights
Based on application, the pain management devices market is segmented into production neuropathic pain, cancer
pain, facial pain and migraine, musculoskeletal pain, and others. The neuropathic pain segment held the largest share
of the market in 2019; however, the musculoskeletal pain segment is estimated to register the highest CAGR in the
market during the forecast period.
Strategic Insights
Product launches and FDA approval strategies are commonly adopted by companies to expand their footprint and
product portfolio worldwide in order to meet the growing demand. The market players operating in the pain
management devices market adopt the strategy of collaborations to enlarge customer base across the world, which
also permits the players to maintain their brand name globally.
Dominating Segments
8. Global Pain Management Devices Market – By Application
Neuropathic Pain
Cancer Pain
Facial Pain and Migraine
Musculoskeletal Pain
Others
Dominating Segments
9. Leading Players
Pain Management Devices Market
Company Profiles
Medtronic plc
Abbott (St. Jude Medical)
Boston Scientific Corporation
Hospira, Inc.
Halyard Health, Inc
Smiths Medical
B. Braun Melsungen AG
Neurotech NA, Inc.
BD
Nevro Corp.
